The present invention provides an early insulin secretion stimulator consisting of a triterpene represented by the following general formula (1) and/or a triterpene represented by the following general formula (2).
[where R1 represents COOH, etc., R11 and R12 represent CH2OH, etc., X1 represents hydrogen or OH and X11, X12, X21 and X22 represent OH, etc.]
Terpenoids. XXXI.<sup>1</sup> The Structure and Stereochemistry of Medicagenic Acid<sup>2</sup>
作者:Carl Djerassi、D. B. Thomas、A. L. Livingston、C. Ray Thompson
DOI:10.1021/ja01576a057
日期:1957.10
Insulin secretion potentiator
申请人:Matsuyama Futoshi
公开号:US20050143464A1
公开(公告)日:2005-06-30
The present invention provides early insulin secretion stimulators consisting of triterpenes represented by the following general formula (1) and/or triterpenes represented by the following general formula (2).
[where R
1
represents COOH, etc., R
11
and R
12
represent CH
2
OH, etc., X
1
represents hydrogen or OH and X
11
, X
12
, X
21
and X
22
represent OH, etc.]
[EN] GLUCONEOGENESIS INHIBITING AGENT<br/>[FR] AGENTS D'INHIBITION DE LA GLUCONEOGENESE
申请人:USE TECHNO CORP
公开号:WO2006054370A1
公开(公告)日:2006-05-26
[EN] The present invention provides a gluconeogenesis inhibiting agent containing as an active ingredient corosolic acid, an analogous compound of corosolic acid, or a pharmaceutically acceptable salt thereof. [FR] La présente invention concerne un agent d'inhibition de la gluconéogenèse, contenant en tant qu'ingrédient actif de l'acide corosolique, un analogue de l'acide corosolique ou l'un de leurs sels pharmaceutiquement acceptables.
Eade,R.A. et al., Australian Journal of Chemistry, 1963, vol. 16, p. 900 - 905